• This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Sun - Fri 8:00 - 20:30
Cionic Neural Sleeve

Cionic Neural Sleeve Recognized at IDEA 2023 With Multiple Wins

CIONIC, the innovative bionic clothing company dedicated to improving mobility with the breakthrough FDA-cleared Cionic Neural Sleeve, was recognized with multiple top awards at the 2023 International Design Excellence Awards (IDEA) by the Industrial Designers Society of America (IDSA), including a gold award for Digital Interaction, and a silver for design in the Medical & Health category.

Read more →
Orizuru Therapeutics

PeptiGrowth Inc. and Orizuru Therapeutics, Inc. Enter into Joint Development of Novel Synthetic Peptide Based Growth Factor

OZTx, with the aim of social implementation of cell therapy products and innovative iPS cell-related technologies (platform innovation), is conducting research and development of regenerative medicine using iPS cell-derived cardiomyocytes and islet cells and supports commercialization of development candidate seeds through collaboration with commercial partnerships and academic institutions.

Read more →
Patient recommendations for better pain management

Pain Management Issues in Potentially Vulnerable Patient Populations

Pain Insights conducted a patient-centered survey to better understand the needs of patients with recurrent and chronic pain, review pain management needs in potentially vulnerable patient populations across the lifespan, such as Veterans, the elderly, unborn children, and those with genetic diseases, and to present information on potential pain-related initiatives.

Read more →
prodisc

Centinel Spine® to Present at 2023 Castellvi Spine Symposium

Centinel Spine®, LLC, ("the Company") a leading global medical device company addressing cervical and lumbar spinal disease by providing the most robust and clinically-proven total disc replacement (TDR) technology platform in the world (prodisc®), will present at the 2023 Castellvi Spine Symposium.

Read more →
Epinephrine Injection

American Regent introduces FDA-approved Epinephrine Injection

Epinephrine Injection, USP, is indicated for emergency treatment of allergic reactions (Type I), including anaphylaxis, which may result from insect stings or bites, foods, drugs, sera, diagnostic testing substances and other allergens, as well as idiopathic anaphylaxis or exercise-induced anaphylaxis. Epinephrine is also indicated to increase mean arterial blood pressure in adult patients with hypotension associated with septic shock.

Read more →
MRI Image of Brain

Stroke Survivor Makes Remarkable Recovery Using His Own Stem Cells

Christopher Martin, a stroke survivor, has made a remarkable recovery following his participation in the Neurologic Stem Cell Treatment Study. The consequences of his hemorrhagic stroke in April 2016 were terrible. Martin reports: “ I pretty much went straight into atrophy and spasticity. I could hardly do anything with my right side. My shoulder was subluxed and I wore a Kafo orthosis and a shoulder brace. I hated every minute of my life”.

Read more →
PerkinElmer's EnVision® Nexus

PerkinElmer Launches EnVison Nexus Multimode Plate

PerkinElmer, Inc., (NYSE: PKI), a global leader committed to innovating for a healthier world, launched the EnVision® Nexus™ system, its fastest and most sensitive multimode plate reader to date, designed for demanding high-throughput screening (HTS) applications and to accelerate drug discovery efforts.

Read more →